Is Alcon Inc. (ALC) a Buy, Sell, or Hold?
Alcon Inc.
NYSE:ALC
$66.86 USD
-$2.14 (-3.1%)
- Volume
- 3.4M
- Average Volume
- 2.11M
- Market Capitalization
- $32.61B
- P/E Ratio
- 40.28
- Dividend Yield
- 0.54%
- Price Target
- $81.50
- Year High
- $92.55
- Year Low
- $61.84
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.20
- Current Ratio
- $2.20
| Source | Headline |
|---|---|
|
Why Alcon (ALC) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com - 2026-07-14 10:40:33 |
|
Buy 3 AI-Led Medical Devices Laggards of 1H Set to Gather Pace in 2H
ISRG, IDXX and ALC are three AI-driven medical device laggards with strong business momentum and improving earnings estimates for a potential 2H rebound. zacks.com - 2026-07-14 08:41:07 |
|
Alcon & RxSight Collaborate to Develop Adjustable PCIOL Technology
ALC is developing adjustable presbyopia-correcting lenses that pair advanced optics with post-surgery light adjustment. zacks.com - 2026-07-13 10:40:46 |
|
DELL & 3 More Stocks With Strong Interest Coverage to Buy Now
DELL, Brinker International, Tapestry and Alcon pair strong interest coverage with solid growth prospects amid elevated borrowing costs. zacks.com - 2026-07-13 09:56:52 |
|
RxSight Q2 Sales Sink 20% as Alcon Deal Bolsters 2026 Outlook
RxSight NASDAQ: RXST reported preliminary second-quarter financial results and provided updates on its product pipeline following a newly announced strategic collaboration agreement with Alcon, with management pointing to both near-term commercial headwinds and longer-term opportunities in adjustable intraocular lenses. marketbeat.com - 2026-07-10 22:02:11 |
|
Wall Street Analysts Predict a 27.75% Upside in Alcon (ALC): Here's What You Should Know
The mean of analysts' price targets for Alcon (ALC) points to a 27.8% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock. zacks.com - 2026-07-09 10:56:12 |
|
ALC vs. IDXX: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Instruments sector might want to consider either Alcon (ALC) or Idexx Laboratories (IDXX). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com - 2026-07-07 12:41:10 |
|
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
ALISO VIEJO, Calif., July 06, 2026 (GLOBE NEWSWIRE) -- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced a non-exclusive collaboration to jointly develop adjustable presbyopia-correcting intraocular lenses (PCIOLs). globenewswire.com - 2026-07-06 16:15:00 |
|
Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs
Non-exclusive license agreement for the development and commercialization of novel post-operative light adjustable PCIOL technologies Collaboration aims to combine best-in-class PCIOL optics with first-in-class platform to enable fine-tuning of visual outcomes after cataract surgery ALISO VIEJO, Calif. , July 06, 2026 (GLOBE NEWSWIRE) -- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, and RxSight, Inc. globenewswire.com - 2026-07-06 16:15:00 |
|
Here's Why Alcon (ALC) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com - 2026-07-06 10:51:09 |
|
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon's new platforms, lenses and dry eye momentum support growth, but macro pressures, tariffs and fierce competition weigh on its outlook. zacks.com - 2026-07-02 15:16:17 |
|
MiniMed appoints Alcon CEO David Endicott and Linnea Burman to its Board of Directors
David Endicott, Chief Executive Officer of Alcon, brings global healthcare leadership and public company experience; Linnea Burman adds MedTech operating depth NORTHRIDGE, Calif., June 29, 2026 /PRNewswire/ -- MiniMed (Nasdaq: MMED), a global leader in diabetes technology, today announced that David Endicott and Linnea Burman have joined its Board of Directors, effective today, expanding the Board from nine to 11 members. prnewswire.com - 2026-06-29 09:04:00 |
|
Alcon (ALC) is a Top-Ranked Value Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com - 2026-06-22 10:41:20 |
|
Alcon Launches UNITY® CS at COS 2026, Advancing the Next Generation of Surgical Innovation in Canada
MONTRÉAL--(BUSINESS WIRE)--Alcon announces the launch and Canadian availability of UNITY® Cataract System (CS), Alcon's next-generation standalone cataract surgical platform. businesswire.com - 2026-06-15 09:43:00 |
|
Mexican Gold Announces Subscription Receipt Financing and Loan to Alcon Silver in Connection with Arrangement
Vancouver, British Columbia--(Newsfile Corp. - June 15, 2026) - Mexican Gold Mining Corp. (TSXV: MEX) ("Mexican Gold" or the "Company") and Alcon Silver Corp. ("Alcon") announce that, in connection with the previously announced arrangement agreement dated April 8, 2026 between the Company and Alcon (the "Arrangement Agreement"), the Company intends to complete a non-brokered private placement of up to 11,250,000 subscription receipts of the Company (the "Subscription Receipts") at a price of $0.20 per Subscription Receipt, for aggregate gross proceeds of up to $2,250,000 (the "Offering"). The Offering constitutes a concurrent financing to the Arrangement (as defined below) and is subject to acceptance of the TSX Venture Exchange (the "TSXV"). newsfilecorp.com - 2026-06-15 07:00:00 |
|
Is It Too Late to Buy Alcon Inc (ALC) After 3.7% Rally? GF Value Says Undervalued
On June 04, 2026, Alcon Inc (ALC) shares rose 3.7% today, closing at $66.58. The stock has seen considerable volatility over the past year, with a 52-week high gurufocus.com - 2026-06-04 17:53:00 |
|
Alcon: Product Cycle Reset Creates An Attractive Entry Point (Initiating Buy)
Alcon receives a buy rating, driven by the launch of Tryptyr in the mature dry eye disease market. Tryptyr's unique mechanism and rapid tear production differentiate it, but commercial adoption hinges on refill rates, payer coverage, and patient persistence. ALC's robust commercial footprint and strong balance sheet support ongoing R&D, M&A, dividends, and buybacks, mitigating financing risks. seekingalpha.com - 2026-05-31 06:11:04 |
|
Is it a Prudent Move to Retain ALC Stock in Your Portfolio Now?
Alcon's Surgical and Vision Care units returned to 6% growth in Q1 2026, but tariffs, macro pressure and fierce competition still loom. zacks.com - 2026-05-28 11:06:10 |
|
Here's Why Alcon (ALC) is a Strong Value Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. zacks.com - 2026-05-07 10:40:41 |
|
Algoma Central Corporation Reports Financial Results for the 2026 First Quarter
ST. CATHARINES, Ontario--(BUSINESS WIRE)--Algoma Central Corporation (TSX: ALC) ("Algoma", the "Company") today reported its results for the three months ended March 31, 2026. Algoma reported first quarter revenues of $127,781, compared to revenues of $107,201 in 2025. Net earnings for the first quarter were $2,224 compared to a loss of $23,280 in 2025. Earnings in 2026 include one-time net gains totaling $18,881 in the period. Due to the closing of the canal system and the winter weather condi. businesswire.com - 2026-05-07 09:08:00 |
|
Alcon Inc. (ALC) Q1 2026 Earnings Call Transcript
Alcon Inc. (ALC) Q1 2026 Earnings Call Transcript seekingalpha.com - 2026-05-07 07:39:18 |
|
Swiss eye care firm Alcon's quarterly revenue rises, driven by product launches
Swiss-American eye care company Alcon reported a 10% rise in its quarterly revenue, citing recent product launches as main drivers. reuters.com - 2026-05-06 01:08:16 |
|
New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds
GENEVA--(BUSINESS WIRE)--New Product Launches Drive Alcon's First-Quarter 2026 Growth as Momentum from Unity and Tryptyr Builds. businesswire.com - 2026-05-05 16:30:00 |
|
ALC vs. PEN: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical - Instruments stocks have likely encountered both Alcon (ALC) and Penumbra (PEN). But which of these two stocks presents investors with the better value opportunity right now? zacks.com - 2026-05-05 12:41:09 |
|
Alcon Announces Results of 2026 Annual General Meeting
GENEVA--(BUSINESS WIRE)--Alcon Announces Results of 2026 Annual General Meeting. businesswire.com - 2026-04-30 16:30:00 |
|
Alcon Inc (ALC) Stock Down 3.1% -- Now Undervalued? GF Score: 80/100
On April 21, 2026, Alcon Inc (ALC) shares fell 3.1% today to a current price of $77.82. This decline comes amid a 52-week range of $71.55 to $99.20, reflecting gurufocus.com - 2026-04-21 17:38:00 |
